Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients — Stella

Home/Biliary Tract Cancer/Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

View on ClinicalTrials.gov

Recruiting

Back to Biliary Tract Cancer trials

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

France

Institute Mutualiste Montsouris, Paris

Centre Eugène Marquis, Rennes

United Kingdom

University College London, London

Key details

Phase

Safety & dosing

Sponsor

UNICANCER

Collaborators

Cancer Research UK & UCL Cancer Trials Centre, Belgian Group of Digestive Oncology

Enrollment target

~72 participants

Started

October 2025

Primary completion

August 2027

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.